Bristol-Myers Squibb moving 90 manufacturing jobs from New York facility

Bristol-Myers Squibb building
The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. (Bristol-Myers Squibb)

Bristol-Myers Squibb will move about 90 manufacturing jobs from its DeWitt, New York, facility to plants in Massachusetts and New Jersey.

The changes are part of the company’s restructuring efforts, Pharmafile reported.

Lisa McCormick Lavery, the company’s director of corporate communications, told the publication that the moves are part of a plan to consolidate related positions within the company that includes transferring other positions from company facilities in Connecticut, Indiana and Seattle to the same two sites.

Survey

Survey: The Critical Role of Innovation in Launching Successful OTC Products

This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card. Take the survey now.

The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. 

The change is expected to be completed by first-quarter 2019; however, they are not expected to have an effect on manufacturing operations at the DeWitt facility.

Suggested Articles

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.

Pfizer is ponying up $500 million on top of $100 million already committed to a gene therapy manufacturing facility in North Carolina.